Epidermolysis Bullosa
📧 Sign up to get email alerts when something new happens for Epidermolysis Bullosa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]
A clinical trial update indicates Phase 1/Phase 2 studies are investigating intravenous immunoglobulin–based therapy targeting collagen VII …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa [Phase 3]
A Phase 3 clinical trial evaluating SD-101 for Epidermolysis Bullosa is not yet recruiting, indicating ongoing development and pending enrol…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis Bullosa [Phase 3]
An open-label extension safety study of SD-101 for Epidermolysis Bullosa is planned (Phase 3) and currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Improve Adherence to Weak or Strong Opioid Analgesics at the Time of Care in Children With Hereditary Epidermolysis Bullosa
A completed clinical trial evaluating adherence to opioid analgesics in children with Epidermolysis bullosa.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: FARD (RaDiCo Cohort) (RaDiCo-FARD)
The RaDiCo-FARD clinical trial sponsored by INSERM is currently recruiting, studying a cohort of patients with inherited skin and ectodermal…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Thera-Clean® Microbubbles System in Patients With Skin Diseases [EARLY_Phase 1]
Northwestern University is enrolling participants in an early-phase 1 trial of the Thera-Clean Microbubbles System for skin diseases, includ…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study [Phase 2]
This is a Phase 2 clinical trial update for TCP-25 Gel in patients with epidermolysis bullosa, including dystrophic and junctional forms. Th…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa [Phase 1]
Phase 1 pilot study update for ELK-003 Eye Drops to treat ocular manifestations of epidermolysis bullosa, currently active/not recruiting.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft® Duo With Debrisoft® Pad in the Debridement of Wounds [NA]
A multicenter, randomized non-inferiority trial is comparing Debrisoft Duo with Debrisoft Pad for wound debridement, with recruitment ongoin…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa [Phase 3]
Phase 3 clinical trial in Japanese patients with epidermolysis bullosa to evaluate the safety and efficacy of Oleogel-S10. Recruitment is on…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III) [Phase 3]
Phase 3 clinical trial evaluating allogeneic ABCB5-positive dermal mesenchymal stromal cells for epidermolysis bullosa; the study is current…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over) [Phase 3]
This clinical trial update describes a Phase III crossover study evaluating allogeneic ABCB5-positive dermal mesenchymal stromal cells for E…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Evaluation of the Efficacy of ROPIVACAINE in Children and Young Adults With Hereditary Epidermolysis Bullosa [NA]
This clinical trial update reports completion of a study evaluating the efficacy of ropivacaine in children and young adults with hereditary…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
A clinical trial update from Amryt Pharma about a study to assess the incidence of skin cancers in patients with epidermolysis bullosa recei…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients [Phase 3]
A Phase 3b trial of EB-101 for recessive dystrophic epidermolysis bullosa (DEB) in new and previously EB-101 treated patients is active but …
-
CLINICAL_TRIALS research · 2025-06-09Clinical Trial Update: Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) [Phase 1, Phase 2]
A clinical trial update evaluating efgartigimod alfa (Vyvgart) to treat bullous diseases by targeting collagen VII antibodies in Epidermolys…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa
A pilot study by ProgenaBiome evaluating the role of gut flora in Epidermolysis Bullosa has been withdrawn. The study covered Epidermolysis …
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Reproductive Options in Inherited Skin Diseases
A clinical trial update indicates a study on reproductive options for inherited skin diseases is ongoing at Maastricht University Medical Ce…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Maastricht University Medical Center is conducting a qualitative study to explore reproductive counseling for patients with genodermatoses a…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Characterization of the Microbiome in Colonized Dystrophic and Junctional Epidermolysis Bullosa Wounds Before and After Use of APR-TD011 ® Spray Solution [EARLY_Phase 1]
This early-phase (Phase 1) trial characterized the wound microbiome in dystrophic and junctional Epidermolysis Bullosa and examined changes …
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Pregabalin Treatment for RDEB Pain and Itch [Phase 3]
Phase 3 trial of pregabalin for pain and itch in recessive dystrophic epidermolysis bullosa has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs [Phase 2]
Phase 2 trial results evaluating allogeneic hematopoietic stem cell transplantation and serial donor mesenchymal stromal cells for biochemic…
-
CLINICAL_TRIALS research · 2024-04-03Clinical Trial Update: Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigated biochemical correction of severe Epidermolysis Bullosa using allogeneic hematopoietic stem cell tran…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Study of Cellutome System for Treatment of Individual Lesions in EB Pts [NA]
Completed clinical trial of the Cellutome System for treating individual lesions in Epidermolysis Bullosa; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]
Phase 1/2 clinical trial update for a gene transfer approach targeting recessive dystrophic epidermolysis bullosa has completed with results…